XORTX Therapeutics Inc (TSE:XRTX) has released an update.
XORTX Therapeutics Inc. has released its condensed interim consolidated financial statements for the first half of 2024, highlighting a decrease in total assets from $5.47 million at the end of 2023 to $4.80 million by June 30, 2024. The company also reported an increased total liabilities from approximately $826,000 to $2.09 million in the same period. These figures reflect the company’s financial movements and position, which are critical for investors tracking the fiscal health and performance of XORTX.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.